INDOLENT B-CELL NON-HODGKIN LYMPHOMA
Clinical trials for INDOLENT B-CELL NON-HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new INDOLENT B-CELL NON-HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for INDOLENT B-CELL NON-HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test radiation boost to supercharge Cancer-Fighting cells
Disease control OngoingThis study is testing if adding a low dose of radiation therapy is safe and practical for patients before they receive a CAR-T cell treatment for B-cell lymphoma that has returned or not responded to other therapies. The goal is to see if this combination can improve outcomes for…
Matched conditions: INDOLENT B-CELL NON-HODGKIN LYMPHOMA
Phase: PHASE1 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New Three-Drug attack on tough lymphomas
Disease control OngoingThis study is testing a new three-drug combination to control B-cell non-Hodgkin lymphoma. It aims to find the safest dose and see if adding a new immunotherapy drug (ALX148) to two existing drugs (rituximab and lenalidomide) helps patients whose cancer has returned or is newly d…
Matched conditions: INDOLENT B-CELL NON-HODGKIN LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC